FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

19338005: 2 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    32597014 Two en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442103019 2 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    2 Is a General adjectival modifier false Inferred relationship Some
    2 Is a Number false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely amoxicillin (as amoxicillin trihydrate) 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely ampicillin (as ampicillin trihydrate) 250 milligram and flucloxacillin (as flucloxacillin sodium) 250 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely fluphenazine hydrochloride 500 microgram and nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely fluphenazine hydrochloride 1.5 milligram and nortriptyline (as nortriptyline hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely amoxicillin (as amoxicillin trihydrate) 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely amoxicillin (as amoxicillin trihydrate) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only articaine and epinephrine (medicinal product) Count of base of active ingredient False 2 Inferred relationship Some
    Enalapril and felodipine only product in oral dose form Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only lanolin and zinc oxide (medicinal product) Count of base of active ingredient False 2 Inferred relationship Some
    Cetirizine and pseudoephedrine only product Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only articaine and epinephrine in parenteral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only cetirizine and pseudoephedrine in oral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only morphine and naltrexone (medicinal product) Count of base of active ingredient False 2 Inferred relationship Some
    Benzocaine and trimethobenzamide only product in rectal dose form Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only benzocaine and trimethobenzamide (medicinal product) Count of base of active ingredient False 2 Inferred relationship Some
    Prednisolone and sulfacetamide only product in ocular dose form Count of base of active ingredient False 2 Inferred relationship Some
    Lanolin and zinc oxide only product in cutaneous dose form Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only prednisolone and sulfacetamide (medicinal product) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only boric acid and salicylic acid (medicinal product) Count of base of active ingredient False 2 Inferred relationship Some
    Carmellose and hydroxyapatite only product Count of base of active ingredient False 2 Inferred relationship Some
    Citric acid and potassium bicarbonate only product in oral dose form Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only boric acid and salicylic acid in cutaneous dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Some
    Carmellose and hydroxyapatite only product in parenteral dose form Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only citric acid and potassium bicarbonate (medicinal product) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only morphine and naltrexone in oral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Some
    Fluorescein stain and oxybuprocaine only product Count of base of active ingredient False 2 Inferred relationship Some
    Enalapril and felodipine only product Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only fluorescein stain and oxybuprocaine in ocular dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Some
    Nicotinic acid 1 g and simvastatin 20 mg prolonged-release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely risperidone 2 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Some 1
    Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely melatonin 2 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Some 1
    Product containing only fluorometholone and sulfacetamide (medicinal product) Count of base of active ingredient False 2 Inferred relationship Some
    Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Count of base of active ingredient False 2 Inferred relationship Some
    Glyceryl trinitrate 2 mg buccal tablet Has presentation strength numerator value False 2 Inferred relationship Some 1
    Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg chewable tablet Count of base of active ingredient False 2 Inferred relationship Some
    Belladonna alkaloid 16.2 mg and opium 30 mg rectal suppository Count of base of active ingredient False 2 Inferred relationship Some
    Hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Fluorometholone and sulfacetamide only product in ocular dose form Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Benserazide and levodopa only product in oral dose form Count of base of active ingredient False 2 Inferred relationship Some
    Benserazide 25 mg and levodopa 100 mg oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 2
    Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Nicotinic acid 750 mg and simvastatin 20 mg prolonged-release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely hydroxyamfetamine hydrobromide 10 milligram/1 milliliter and tropicamide 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Prednisolone acetate 2 mg/g and sulfacetamide sodium 100 mg/g eye ointment Count of base of active ingredient False 2 Inferred relationship Some
    Polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 1 mg oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely nicotinic acid 500 milligram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing only polythiazide and prazosin in oral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Polythiazide and prazosin only product Count of base of active ingredient False 2 Inferred relationship Some
    Metformin hydrochloride 500 mg and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment Count of base of active ingredient False 2 Inferred relationship Some
    Belladonna alkaloid 16.2 mg and opium 60 mg rectal suppository Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Dexamethasone 500 microgram/mL and tobramycin 3 mg/mL eye suspension Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Metformin and saxagliptin only product Count of base of active ingredient False 2 Inferred relationship Some
    Metformin hydrochloride 1 g and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Metformin and saxagliptin only product in oral dose form Count of base of active ingredient False 2 Inferred relationship Some
    Hydrocortisone valerate 2 mg/g cutaneous ointment Has concentration strength numerator value False 2 Inferred relationship Some 1
    Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution Count of base of active ingredient False 2 Inferred relationship Some
    Betamethasone (as betamethasone dipropionate) 500 microgram/g and calcipotriol 50 microgram/g cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Some
    Cetrimide 1.5 mg/mL and chlorhexidine gluconate 150 microgram/mL cutaneous solution Count of base of active ingredient False 2 Inferred relationship Some
    Coal tar 50 mg/g and pine tar 50 mg/g cutaneous gel Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely olopatadine (as olopatadine hydrochloride) 2 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Glyceryl trinitrate 2 mg prolonged-release buccal tablet Has presentation strength numerator value False 2 Inferred relationship Some 1
    Methylphenidate hydrochloride 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Ciprofloxacin 2 mg/mL ear solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Product containing precisely esterified estrogen 1.25 milligram and methyltestosterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Diiodohydroxyquinoline 10 mg/mL and hydrocortisone 10 mg/mL cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely coal tar 60 milligram/1 milliliter and lecithin 4 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely hydrocortisone valerate 2 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1
    Benzalkonium 2.5 mg/g and polyethylene 219 mg/g cutaneous gel Count of base of active ingredient False 2 Inferred relationship Some
    Lactic acid 250 mg/g and salicylic acid 250 mg/g cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely salicylic acid 50 microgram/1 milligram and zinc oxide 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely mequinol 20 milligram/1 milliliter and tretinoin 100 microgram/1 milliliter conventional release cutaneous solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Hydrocortisone acetate 10 mg/mL and pramocaine hydrochloride 10 mg/mL cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely hydrocortisone acetate 25 milligram/1 milliliter and pramocaine hydrochloride 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely benzocaine 10 milligram/1 milliliter and triclosan 2 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Cetrimide 22.5 mg/mL and chlorhexidine gluconate 2.25 mg/mL cutaneous solution Count of base of active ingredient False 2 Inferred relationship Some
    Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL and dexamethasone 1 mg/mL ear suspension Count of base of active ingredient False 2 Inferred relationship Some
    Benzocaine 10 mg/mL and triclosan 2 mg/mL cutaneous spray Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely acetic acid 20 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely cetrimide 5 milligram/1 milliliter and chlorhexidine gluconate (as chlorhexidine) 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Some
    Product containing precisely nitrofural 2 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Some 1

    Start Previous Page 20 of 24 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start